Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Osteosarcoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Mobility Limitation 1Melanoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Transitional Cell 1COVID-19 1Breast Neoplasms 1

Interventions

X-Rays 6Specimen Handling 6Cyclophosphamide 6Phantoms, Imaging 5Magnetic Resonance Spectroscopy 4fludarabine 3Nuclear Medicine Department, Hospital 3Doxorubicin 3Biopsy 3ulixertinib 2tipifarnib 2selpercatinib 2mifamurtide 2ivosidenib 2fludarabine phosphate 2ensartinib 2cabozantinib 2Methotrexate 2Mesna 2Ifosfamide 2Gemcitabine 2Cisplatin 2trastuzumab deruxtecan 1tazemetostat 1talazoparib 1selinexor 1pembrolizumab 1pazopanib 1palbociclib 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Patient Reported Outcome Measures × 30 days × Clear all
NCT07502885 2026-05-05

Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients

St. Jude Children's Research Hospital

Recruiting
300 enrolled
Sarcoma

Sarcoma, Osteosarcoma, Mobility Limitation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡